Transaction overview
NexPhase Capital, LP acquired Empower Community Care, a leading global behavioral health enablement platform, on July 16, 2025. The deal value was undisclosed but falls within NexPhase's typical investment range of $40 million to $150 million. Empower provides evidence-based programs and software tools to support at-risk youth, families, and communities across more than 35 countries.
Deal structure and financing
The transaction’s financial details were not disclosed, including the equity-debt split and any seller retained stake or lock-up terms. NexPhase Capital typically uses a combination of debt from large investment banks and private equity capital to finance acquisitions. The buy-side legal team included Choate, Hall & Stewart, Gowling WLG, Haynes and Boone, and McDermott Will & Emery, while the sell-side was advised by TripleTree and TM Capital with King & Spalding serving as legal counsel.
Strategic context
NexPhase’s acquisition of Empower aims to accelerate the adoption of evidence-based programs and support international expansion for Empower's behavioral health enablement platform. Founded in 2016, Empower offers proprietary, clinically validated services and software tools enabling public systems and care providers to deliver high-quality, outcome-driven treatment primarily for at-risk adolescent populations. NexPhase’s rationale is rooted in the significant growth potential of the behavioral health market, driven by increased awareness and demand for community-based mental health solutions.
Empower’s current shareholders likely divested due to a desire to unlock value from a fast-growing asset with strong operational performance. The deal aligns with NexPhase's focus on making control investments in companies that have reached an inflection point of growth within the healthcare, software, or consumer sectors. Empower’s differentiated model combining clinical validation and scalable technology resonates strongly with NexPhase’s thematic investment approach.
Regulatory path
The acquisition did not require significant regulatory scrutiny as it involves private equity firm NexPhase Capital acquiring a non-provider behavioral health platform without direct competition concerns in specific markets. The transaction is likely to have been reviewed under U.S. antitrust laws, including the Hart-Scott-Rodino (HSR) Act filings if applicable based on asset value thresholds. No other international jurisdictions appear to be involved given Empower’s operations primarily within the United States and no mention of cross-border regulatory hurdles in press materials.